West Pharmaceutical Services Inc Income Statement

1Y3Y5Y7Y10YAll
Download Data
Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1,055.70M1,104.70M1,192.30M1,266.40M1,368.40M1,421.40M1,399.80M1,509.10M1,599.10M1,717.40M1,839.90M2,146.90M2,831.60M2,886.90M2,949.80M2,893.20M
Cost of Revenue 752.10M786.60M853.00M878.70M933.70M973.60M944.00M1,007.70M1,086.20M1,172.00M1,234.20M1,379.10M1,655.80M1,750.70M1,820.60M1,894.70M
Gross Profit 303.60M318.10M339.30M387.70M434.70M447.80M455.80M501.40M512.90M545.40M605.70M767.80M1,175.80M1,136.20M1,129.20M998.50M
Operating items
Research & Development 19.90M23.90M29.10M33.20M37.90M37.30M34.10M36.80M39.10M40.30M38.90M46.90M52.80M58.50M68.40M69.10M
Selling, General & Administrative 177.70M187.70M191.10M218.10M234.90M228.70M233.00M239.60M246.00M262.90M272.70M302.00M362.80M316.90M353.40M338.50M
Restructuring Costs 8.50M15.80M9.50M1.30M-0.50M26.40M9.10M
Other Operating Expenses -1.80M-0.20M0.10M-3.90M4.80M
Operating Expenses 206.10M227.40M229.70M252.60M272.30M266.00M267.10M302.80M285.10M312.30M311.60M348.90M415.60M375.40M421.80M407.60M
Operating Income 97.50M90.70M109.60M135.10M162.40M182.00M128.60M195.20M225.80M240.30M296.60M406.90M752.30M734.00M676.00M569.90M
EBIT 97.50M90.70M109.60M135.10M162.40M182.00M128.60M195.20M225.80M240.30M296.60M406.90M752.30M734.00M676.00M569.90M
Non-operating items
Interest & Investment Income 0.80M0.60M1.30M1.80M1.90M3.50M1.60M1.10M1.30M2.10M3.80M1.40M1.00M5.10M28.00M19.60M
Other Non Operating Income -0.20M-11.60M-0.20M-2.70M3.10M6.70M-0.10M1.20M3.80M-51.30M3.00M-1.00M
Non Operating Income -0.20M-0.10M4.20M-1.30M0.50M0.20M-60.10M-29.80M3.10M6.70M-4.80M-12.00M-7.90M-51.30M-31.40M-21.00M
Net income details
EBT 83.10M74.50M92.70M108.60M147.10M169.00M116.10M189.80M222.40M240.70M291.80M401.30M748.90M679.90M698.00M585.50M
Tax Provisions 18.30M13.60M23.50M32.70M40.20M47.20M26.30M54.40M80.90M41.40M59.00M72.50M107.20M114.70M122.30M107.50M
Profit After Tax 72.60M65.30M75.50M80.70M112.30M127.10M95.60M143.60M150.70M206.90M241.70M346.20M661.80M585.90M593.40M492.70M
Equity Income 3.00M4.40M6.30M4.80M5.40M5.30M5.80M8.20M9.20M7.60M8.90M17.40M20.10M20.70M17.70M14.70M
Investment Income 35.00M
Income from Continuing Operations 64.80M60.90M69.20M75.90M106.90M121.80M89.80M135.40M141.50M199.30M232.80M328.80M641.70M565.20M575.70M478.00M
Consolidated Net Income 64.80M60.90M69.20M75.90M106.90M121.80M89.80M135.40M141.50M199.30M232.80M328.80M641.70M565.20M575.70M478.00M
Income towards Parent Company 64.80M60.90M69.20M75.90M106.90M121.80M89.80M135.40M141.50M199.30M232.80M328.80M641.70M565.20M575.70M478.00M
Net Income towards Common Stockholders 72.60M60.90M69.20M75.90M106.90M121.80M89.80M135.40M141.50M199.30M232.80M328.80M641.70M565.20M575.70M478.00M
Additional items
EPS (Basic) 2.211.961.121.191.611.791.331.962.042.803.274.688.897.877.986.75
EPS (Weighted Average and Diluted) 2.121.891.081.151.571.751.301.911.992.743.214.578.677.737.886.69
Shares Outstanding (Weighted Average) 66.00M66.60M67.43M68.25M69.84M71.07M72.09M73.18M74.25M74.08M73.99M74.10M74.08M74.03M73.99M72.42M
Shares Outstanding (Diluted Average) 36.30M36.70M74.00M71.80M71.40M72.80M73.80M75.00M75.80M75.40M75.40M75.80M76.30M75.80M75.30M73.70M
EBITDA 97.50M90.70M109.60M135.10M162.40M182.00M128.60M195.20M225.80M240.30M296.60M406.90M752.30M734.00M676.00M569.90M
Interest Expenses 17.60M16.80M18.20M16.70M17.00M16.50M14.10M8.10M7.80M8.40M8.50M8.20M8.20M7.90M9.00M3.00M
Tax Rate 22.02%18.26%25.35%30.11%27.33%27.93%22.65%28.66%36.38%17.20%20.22%18.07%14.31%16.87%17.52%18.36%